Acitretin in psoriasis: An overview of adverse effects
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 41 (3) , S7-S12
- https://doi.org/10.1016/s0190-9622(99)70359-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics of acitretin and etretinateJournal of the American Academy of Dermatology, 1998
- SYSTEMIC RETINOIDSDermatologic Clinics, 1998
- Current Use and Future Potential Role of Retinoids in DermatologyDrugs, 1997
- Conversion of Acitretin to Etretinate in Psoriatic Patients Is Influenced by EthanolJournal of Investigative Dermatology, 1993
- Acitretin and EtretinateDermatologic Clinics, 1993
- A potentially new metabolic pathway: ethyl esterification of acitretinXenobiotica, 1992
- EtretinateArchives of Dermatology, 1989
- Overview of Recent Clinical Pharmacokinetic Studies with Acitretin (Ro 10-1670, Etretin)Dermatology, 1989
- Food Increases the Bioavailability of AcitretinThe Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of Etretin and Etretinate during Long-Term Treatment of Psoriasis PatientsBasic & Clinical Pharmacology & Toxicology, 1988